Prioritization of neurodevelopmental disease genes by discovery of new mutations.
Prioritization of neurodevelopmental disease genes by discovery of new mutations.
复制标题
DOI:
10.1038/nn.3703
复制
发表时间:
2014-06
影响因子:
25
通讯作者:
Eichler, Evan E.
中科院分区:
文献类型:
--
作者:
Hoischen, Alexander;Krumm, Niklas;Eichler, Evan E.
Advances in genome sequencing technologies have begun to revolutionize neurogenetics allowing the full spectrum of genetic variation to be better understood in relationship to disease. Exome sequencing of hundreds to thousands of samples from patients with autism spectrum disorder, intellectual disability, epilepsy, and schizophrenia provide strong evidence of the importance of de novo and gene-disruptive events. There are now several hundred new candidate genes and targeted resequencing technologies that allow screening of dozens of genes in tens of thousands of individuals with high specificity and sensitivity. The decision of which genes to pursue depends on numerous factors including recurrence, prior evidence of overlap with pathogenic copy number variants, the position of the mutation within the protein, the mutational burden among healthy individuals, and membership of the candidate gene within disease-implicated protein networks. We discuss these emerging criteria for gene prioritization and the potential impact on the field of neuroscience.
登录
查看更多内容
影响因子:
3.5
作者:
Banka, S.;Howard, E.;Donnai, D.
通讯作者:
Donnai, D.
影响因子:
30.8
作者:
Hoischen, Alexander;van Bon, Bregje W. M.;Veltman, Joris A.
通讯作者:
Veltman, Joris A.
影响因子:
9.8
作者:
Gibson, William T.;Hood, Rebecca L.;Jones, Steven J. M.
通讯作者:
Jones, Steven J. M.
影响因子:
7
作者:
Hiatt JB;Pritchard CC;Salipante SJ;O'Roak BJ;Shendure J
通讯作者:
Shendure J
影响因子:
4.4
作者:
Carter H;Douville C;Stenson PD;Cooper DN;Karchin R
通讯作者:
Karchin R